[Cerebral emission computer tomography with 123I-isopropylamphetamine in aphasic patients]. 1986

M Fröscher-Huerkamp, and H A Linck, and H J Biersack

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001925 Brain Damage, Chronic A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions. Encephalopathy, Chronic,Chronic Encephalopathy,Chronic Brain Damage
D002560 Cerebrovascular Circulation The circulation of blood through the BLOOD VESSELS of the BRAIN. Brain Blood Flow,Regional Cerebral Blood Flow,Cerebral Blood Flow,Cerebral Circulation,Cerebral Perfusion Pressure,Circulation, Cerebrovascular,Blood Flow, Brain,Blood Flow, Cerebral,Brain Blood Flows,Cerebral Blood Flows,Cerebral Circulations,Cerebral Perfusion Pressures,Circulation, Cerebral,Flow, Brain Blood,Flow, Cerebral Blood,Perfusion Pressure, Cerebral,Pressure, Cerebral Perfusion
D004734 Energy Metabolism The chemical reactions involved in the production and utilization of various forms of energy in cells. Bioenergetics,Energy Expenditure,Bioenergetic,Energy Expenditures,Energy Metabolisms,Expenditure, Energy,Expenditures, Energy,Metabolism, Energy,Metabolisms, Energy
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000662 Amphetamines Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.

Related Publications

M Fröscher-Huerkamp, and H A Linck, and H J Biersack
July 1984, Deutsche medizinische Wochenschrift (1946),
M Fröscher-Huerkamp, and H A Linck, and H J Biersack
December 1984, Lancet (London, England),
M Fröscher-Huerkamp, and H A Linck, and H J Biersack
August 1984, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
M Fröscher-Huerkamp, and H A Linck, and H J Biersack
September 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
M Fröscher-Huerkamp, and H A Linck, and H J Biersack
January 1989, European neurology,
M Fröscher-Huerkamp, and H A Linck, and H J Biersack
February 1987, Nuklearmedizin. Nuclear medicine,
M Fröscher-Huerkamp, and H A Linck, and H J Biersack
July 1994, European journal of nuclear medicine,
M Fröscher-Huerkamp, and H A Linck, and H J Biersack
January 2009, BMJ case reports,
M Fröscher-Huerkamp, and H A Linck, and H J Biersack
August 1990, Kaku igaku. The Japanese journal of nuclear medicine,
Copied contents to your clipboard!